Prominin-1 (CD133): Molecular and cellular features across species

Advances in Experimental Medicine and Biology

Volumn 777, Issue , 2013, Pages 3-24

  Corbeil, Denis ^a   Karbanová, Jana ^a   Fargeas, Christine A ^a   Jászai, József ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cancer; CD133; Eye; Prominin; Splice variant; Stem cell

Indexed keywords

MEMBRANE PROTEIN; PROMININ 1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CYTOLOGY; CYTOSKELETON; DIMERIZATION; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENE PRODUCT; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; IMMUNOREACTIVITY; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR; PRIORITY JOURNAL; PROM1 GENE; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; START CODON; STEM CELL; ANIMAL; CELL MEMBRANE; EPITHELIUM CELL; METABOLISM;

MUS;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; NEOPLASTIC STEM CELLS;

EID: 84934443592     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5894-4_1     Document Type: Article

References (157)

1. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755-768
2. Baccelli I, Trumpp A (2012) The evolving concept of cancer and metastasis stem cells. J Cell Biol 198:281-293
3. Weigmann A, Corbeil D, Hellwig A, Huttner WB (1997) Prominin, a novel microvilli-speci fi c polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 94:12425-12430
4. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M et al (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012
5. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R et al (1997) A novel fi ve-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90:5013-5021
6. Corbeil D, Röper K, Weigmann A, Huttner WB (1998) AC133 hematopoietic stem cell antigen - human homologue of mouse kidney prominin or distinct member of a novel protein family. Blood 91:2625-2626
7. Miraglia S, Godfrey W, Buck D (1998) A response to AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood 91:4390-4391
8. Corbeil D, Röper K, Hellwig A, Tavian M, Miraglia S et al (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275:5512-5520
9. Florek M, Haase M, Marzesco A-M, Freund D, Ehninger G et al (2005) Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319:15-26
10. Maw MA, Corbeil D, Koch J, Hellwig A, Wilson-Wheeler JC et al (2000) A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet 9:27-34
11. Fargeas CA, Joester A, Missol-Kolka E, Hellwig A, Huttner WB et al (2004) Identi fication of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci 117:4301-4311
12. Jászai J, Janich P, Farkas LM, Fargeas CA, Huttner WB et al (2007) Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice. Histochem Cell Biol 128:409-419
13. Karbanová J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P et al (2008) The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 56:977-993
14. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J et al (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111-2120
15. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ et al (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457:603-607
16. Fargeas CA, Florek M, Huttner WB, Corbeil D (2003) Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem 278: 8586-8596
17. Yu Y, Flint A, Dvorin EL, Bischoff J (2002) AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 277:20711-20716
18. Fargeas CA, Corbeil D, Huttner WB (2003) AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells 21:506-508
19. Fargeas CA, Fonseca AV, Huttner WB, Corbeil D (2006) Prominin-1 (CD133): from progenitor cells to human diseases. Future Lipidol 1:213-225
20. Corbeil D, Fargeas CA, Huttner WB (2001) Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein. Biochem Biophys Res Commun 285:939-944
21. McGrail M, Batz L, Noack K, Pandey S, Huang Y et al (2010) Expression of the zebra fi sh CD133/prominin1 genes in cellular proliferation zones in the embryonic central nervous system and sensory organs. Dev Dyn 239:1849-1857
22. Jászai J, Fargeas CA, Graupner S, Tanaka EM, Brand M et al (2011) Distinct and conserved prominin-1/CD133-positive retinal cell populations identi fi ed across species. PLoS One 6:e17590
23. Han Z, Papermaster DS (2011) Identi fication of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues. Mol Vis 17:1381-1396
24. Zelhof AC, Hardy RW, Becker A, Zuker CS (2006) Transforming the architecture of compound eyes. Nature 443:696-699
25. Jászai J, Fargeas CA, Florek M, Huttner WB, Corbeil D (2007) Focus on molecules: prominin- 1 (CD133). Exp Eye Res 85:585-586
26. Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu E et al (2009) The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 48:3998-4007
27. Corbeil D, Röper K, Fargeas CA, Joester A, Huttner WB (2001) Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2:82-91
28. Gaboriaud C, Bissery V, Benchetrit T, Mornon JP (1987) Hydrophobic cluster analysis: an Efficient new way to compare and analyse amino acid sequences. FEBS Lett 224:149-155
29. Fargeas CA, Huttner WB, Corbeil D (2007) Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antigens 69:602-606
30. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA et al (2004) Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103:2055-2061
31. Pleshkan VV, Vinogradova TV, Sverdlov ED (2008) Methylation of the prominin 1 TATAless main promoters and tissue specificity of their transcript content. Biochim Biophys Acta 1779:599-605
32. Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE et al (2008) Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 68:8094-8103
33. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E et al (2008) Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 18:1037-1046
34. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E et al (2009) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28:209-218
35. Campbell EA, O'Hara L, Catalano RD, Sharkey AM, Freeman TC et al (2006) Temporal expression pro fi ling of the uterine luminal epithelium of the pseudo-pregnant mouse suggests receptivity to the fertilized egg is associated with complex transcriptional changes. Hum Reprod 21:2495-2513
36. Husain SM, Shou Y, Sorrentino BP, Handgretinger R (2006) Isolation, molecular cloning and in vitro expression of rhesus monkey (Macaca mulatta) prominin-1.s1 complementary DNA encoding a potential hematopoietic stem cell antigen. Tissue Antigens 68:317-324
37. Corbeil D, Joester A, Fargeas CA, Jászai J, Garwood J et al (2009) Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. Glia 57:860-874
38. Hoegg S, Brinkmann H, Taylor JS, Meyer A (2004) Phylogenetic timing of the fi sh-speci fi c genome duplication correlates with the diversi fication of teleost fi sh. J Mol Evol 59:190-203
39. Sheng M, Sala C (2001) PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 24:1-29
40. Huttner WB, Zimmerberg J (2001) Implications of lipid microdomains for membrane curvature, budding and fi ssion. Curr Opin Cell Biol 13:478-484
41. Zhou F, Cui C, Ge Y, Chen H, Li Q et al (2010) Alpha2,3-Sialylation regulates the stability of stem cell marker CD133. J Biochem 148:273-280
42. Sgambato A, Puglisi MA, Errico F, Rafanelli F, Boninsegna A et al (2010) Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection. J Cell Physiol 224:234-241
43. Mak AB, Blakely KM, Williams RA, Penttilä PA, Shukalyuk AI et al (2011) CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem 286:41046-41056
44. Hemmoranta H, Satomaa T, Blomqvist M, Heiskanen A, Aitio O et al (2007) N-glycan structures and associated gene expression re fl ect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells. Exp Hematol 35:1279-1292
45. Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L et al (2010) The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 70:719-729
46. Lardon J, Corbeil D, Huttner WB, Ling Z, Bouwens L (2008) Stem cell marker prominin- 1/ AC133 is expressed in duct cells of the adult human pancreas. Pancreas 36:e1-e6
47. Immervoll H, Hoem D, Steffensen OJ, Miletic H, Molven A (2011) Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem 59:441-455
48. Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A (2008) Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 8:48
49. Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in de fi ning cancer stem cells. J Mol Med 86:1025-1032
50. Fargeas CA, Karbanová J, Jászai J, Corbeil D (2011) CD133 and membrane microdomains: old facets for future hypotheses. World J Gastroenterol 17:4149-4152
51. Dubreuil V, Marzesco A-M, Corbeil D, Huttner WB, Wilsch-Bräuninger M (2007) Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1. J Cell Biol 176:483-495
52. Florek M, Bauer N, Janich P, Wilsch-Bräuninger M, Fargeas CA et al (2007) Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into the urine. Cell Tissue Res 328:31-47
53. Giebel B, Corbeil D, Beckmann J, Höhn J, Freund D et al (2004) Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 104:2332-2338
54. Fonseca AV, Freund D, Bornhäuser M, Corbeil D (2010) Polarization and migration of hematopoietic stem and progenitor cells rely on the RhoA/ROCK I pathway and an active reorganization of the microtubule network. J Biol Chem 285:31661-31671
55. Röper K, Corbeil D, Huttner WB (2000) Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2:582-592
56. Corbeil D, Marzesco A-M, Fargeas CA, Huttner WB (2010) Prominin-1, a distinct cholesterol- binding membrane protein, and the organization of the apical plasma membrane of epithelial cells. Subcell Biochem 51:399-423
57. Janich P, Corbeil D (2007) GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett 581:1783-1787
58. Gillette JM, Larochelle A, Dunbar CE, Lippincott-Schwartz J (2009) Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nat Cell Biol 11: 303-305
59. Taïeb N, Maresca M, Guo XJ, Garmy N, Fantini J et al (2009) The fi rst extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett 278:164-173
60. Marzesco A-M, Janich P, Wilsch-Bräuninger M, Dubreuil V, Langenfeld K et al (2005) Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118:2849-2858
61. Huttner HB, Janich P, Köhrmann M, Jászai J, Siebzehnrubl F et al (2008) The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fl uid offers novel approaches for studying CNS disease. Stem Cells 26:698-705
62. Huttner HB, Corbeil D, Thirmeyer C, Coras R, Köhrmann M et al (2012) Increased membrane shedding-indicated by an elevation of CD133-enriched membrane particles - into the CSF in partial epilepsy. Epilepsy Res 99:101-106
63. Kania G, Corbeil D, Fuchs J, Tarasov KV, Blyszczuk P et al (2005) The somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors. Stem Cells 23:791-804
64. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001) Hematopoietic colony- forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716-10721
65. Carpenter MK, Rosler E, Rao MS (2003) Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5:79-88
66. Hoffman LM, Carpenter MK (2005) Characterization and culture of human embryonic stem cells. Nat Biotechnol 23:699-708
67. Shamblott MJ, Axelman J, Little fi eld JW, Blumenthal PD, Huggins GR et al (2001) Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci USA 98:113-118
68. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R (2002) Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391-4396
69. Ito Y, Hamazaki TS, Ohnuma K, Tamaki K, Asashima M et al (2007) Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol 127:1052-1060
70. Suzuki A, Sekiya S, Onishi M, Oshima N, Kiyonari H et al (2008) Flow cytometric isolation and clonal identi fication of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 48:1964-1978
71. Gashaw I, Dushaj O, Behr R, Biermann K, Brehm R et al (2007) Novel germ cell markers characterize testicular seminoma and fetal testis. Mol Hum Reprod 13:721-727
72. Jászai J, Fargeas CA, Haase M, Farkas LM, Huttner WB et al (2008) Robust expression of prominin-2 all along the adult male reproductive system and urinary bladder. Histochem Cell Biol 130:749-759
73. Han Z, Anderson DW, Papermaster DS (2012) Prominin-1 localizes to the open rims of outer segment lamellae in Xenopus laevis rod and cone photoreceptors. Invest Ophthalmol Vis Sci 53:361-373
74. Bauer N, Fonseca AV, Florek M, Freund D, Jászai J et al (2008) New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 188:127-138
75. Bornhäuser M, Eger L, Oelschlaegel U, Auffermann-Gretzinger S, Kiani A et al (2005) Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells. Leukemia 19:161-165
76. Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E et al (2007) CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res 67:5727-5736
77. Coskun V, Wu H, Blanchi B, Tsao S, Kim K et al (2008) CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci USA 105:1026-1031
78. Mirzadeh Z, Merkle FT, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A (2008) Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell 3:265-278
79. Uchida N, Buck DW, He D, Reitsma MJ, Masek M et al (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97:14720-14725
80. Tamaki S, Eckert K, He D, Sutton R, Doshe M et al (2002) Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res 69:976-986
81. Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK et al (2003) Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 74:838-851
82. Lee A, Kessler JD, Read T-A, Kaiser C, Corbeil D et al (2005) Isolation of neural stem cells from postnatal cerebellum. Nat Neurosci 8:723-729
83. Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus M et al (2005) Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166:545-555
84. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ et al (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545
85. Leong KG, Wang BE, Johnson L, Gao WQ (2008) Generation of a prostate from a single adult stem cell. Nature 456:804-808
86. Alessandri G, Pagano S, Bez A, Benetti A, Pozzi S et al (2004) Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 364:1872-1883
87. Belicchi M, Pisati F, Lopa R, Porretti L, Fortunato F et al (2004) Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 77:475-486
88. Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE et al (2009) Prominin-1/ CD133 marks stem cells and early progenitors in mouse intestine. Gastroenterology 136:2187-2194
89. Gregory CA, Prockop DJ, Spees JL (2005) Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res 306:330-335
90. Pozzobon M, Piccoli M, Ditadi A, Bollini S, Destro R et al (2009) Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy. Stem Cells Dev 18:497-510
91. Ratajczak J, Zuba-Surma E, Klich I, Liu R, Wysoczynski M et al (2011) Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia 25:1278-1285
92. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identi fi es a population of functional endothelial precursors. Blood 95:952-958
93. Asahara T, Kawamoto A (2004) Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287:C572-C579
94. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K et al (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95:3106-3112
95. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C et al (2003) Autologous bonemarrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46
96. Sussman LK, Upalakalin JN, Roberts MJ, Kocher O, Benjamin LE (2003) Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol Ther 2:255-256
97. Lin EH, Hassan M, Li Y, Zhao H, Nooka A et al (2007) Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 110:534-542
98. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E et al (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57:965-969
99. Dome B, Timar J, Dobos J, Meszaros L, Raso E et al (2006) Identi fication and clinical signi fi cance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 66:7341-7347
100. Mehra N, Penning M, Maas J, Beerepoot LV, van Daal N et al (2006) Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res 12:4859-4866
101. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M et al (2005) Granulocyte colonystimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25:296-301
102. Schatteman G (2005) Are circulating CD133+ cells biomarkers of vascular disease? Arterioscler Thromb Vasc Biol 25:270-271
103. Case J, Mead LE, Bessler WK, Prater D, White HA et al (2007) Human CD34 + AC133 + VEGFR- 2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35:1109-1118
104. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F et al (2007) Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 27:1572-1579
105. Singh S, Dirks PB (2007) Brain tumor stem cells: identi fication and concepts. Neurosurg Clin N Am 18:31-38
106. Baersch G, Baumann M, Ritter J, Jurgens H, Vormoor J (1999) Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia. Br J Haematol 107:572-580
107. Buhring HJ, Seiffert M, Marxer A, Weiss B, Faul C et al (1999) AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood 94:832-833
108. Horn PA, Tesch H, Staib P, Kube D, Diehl V et al (1999) Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood 93:1435-1437
109. Cox CV, Diamanti P, Evely RS, Kearns PR, Blair A (2009) Expression of CD133 on leukemia initiating cells in childhood ALL. Blood 113:3287-3296
110. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M et al (2007) Identi fication and expansion of human colon-cancer-initiating cells. Nature 445:111-115
111. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunode fi cient mice. Nature 445:106-110
112. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104:10158-10163
113. Chu P, Clanton DJ, Snipas TS, Lee J, Mitchell E et al (2009) Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 124:1312-1321
114. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178-15183
115. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C et al (2003) Identi fication of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828
116. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J et al (2004) Identi fication of human brain tumour initiating cells. Nature 432:396-401
117. Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C et al (2006) Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54:850-860
118. Liu G, Yuan X, Zeng Z, Tunici P, Ng H et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
119. Bruno S, Bussolati B, Grange C, Collino F, Graziano ME et al (2006) CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 169:2223-2235
120. Rountree CB, Ding W, He L, Stiles B (2009) Expansion of CD133 expressing liver cancer stem cells in liver speci fi c PTEN deleted mice. Stem Cells 27:290-299
121. Ding W, Mouzaki M, You H, Laird JC, Mato J et al (2009) CD133(+) liver cancer stem cells from methionine adenosyl transferase 1A-de fi cient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology 49:1277-1286
122. Zhu Z, Hao X, Yan M, Yao M, Ge C et al (2009) Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma. Int J Cancer 126:2067-2078
123. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M et al (2008) Identi fication and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514
124. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK et al (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3:e2637
125. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323
126. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F et al (2007) Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 6:92-97
127. Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR et al (2009) CD133 expression de fi nes a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27:2875-2883
128. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identi fication of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951
129. Miki J, Furusato B, Li H, Gu Y, Takahashi H et al (2007) Identi fication of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67:3153-3161
130. Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM et al (2005) ABCB5- mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65:4320-4333
131. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ et al (2007) Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20:102-107
132. Bongiorno MR, Doukaki S, Malleo F, Aricò M (2008) Identi fication of progenitor cancer stem cell in lentigo maligna melanoma. Dermatol Ther 21:S1-S5
133. Gedye C, Quirk J, Browning J, Svobodová S, John T et al (2009) Cancer/testis antigens can be immunological targets in clonogenic CD133(+) melanoma cells. Cancer Immunol Immunother 58:1635-1646
134. Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L et al (2008) In vitro identi fication and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS One 3:e3544
135. Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I et al (2008) Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer 8:300
136. Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G et al (2008) Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 3:e3469
137. Yin S, Li J, Hu C, Chen X, Yao M et al (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120:1444-1450
138. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T et al (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351:820-824
139. Rappa G, Fodstad O, Lorico A (2008) The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26:3008-3017
140. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:755-760
141. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173
142. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM et al (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14:123-129
143. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z et al (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848
144. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82
145. Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR et al (2012) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol (2012)
146. Zhang Q, Zul fi qar F, Xiao X, Riazuddin SA, Ahmad Z et al (2007) Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene. Hum Genet 122:293-299
147. Yang Z, Chen Y, Lillo C, Chien J, Yu Z et al (2008) Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J Clin Invest 118:2908-2916
148. Pras E, Abu A, Rotenstreich Y, Avni I, Reish O et al (2009) Cone-rod dystrophy and a frameshift mutation in the PROM1 gene. Mol Vis 15:1709-1716
149. Permanyer J, Navarro R, Friedman J, Pomares E, Castro-Navarro J et al (2010) Autosomal recessive retinitis pigmentosa with early macular affectation caused by premature truncation in PROM1. Invest Ophthalmol Vis Sci 51:2656-2663
150. Littink KW, Koenekoop RK, van den Born LI, Collin RW, Moruz L et al (2010) Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizations. Invest Ophthalmol Vis Sci 51:5943-5951
151. Zacchigna S, Oh H, Wilsch-Bräuninger M, Missol-Kolka E, Jászai J et al (2009) Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration. J Neurosci 29:2297-2308
152. Husain N, Pellikka M, Hong H, Klimentova T, Choe KM et al (2006) The agrin/perlecanrelated protein eyes shut is essential for epithelial lumen formation in the Drosophila retina. Dev Cell 11:483-493
153. Kosodo Y, Röper K, Haubensak W, Marzesco A-M, Corbeil D et al (2004) Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J 23:2314-2324
154. Fonseca AV, Bauer N, Corbeil D (2008) The stem cell marker CD133 meets the endosomal compartment-new insights into the cell division of hematopoietic stem cells. Blood Cells Mol Dis 41:194-195
155. Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J et al (2011) Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis 2:e200
156. Bauer N, Wilsch-Bräuninger M, Karbanová J, Fonseca AV, Strauss D et al (2011) Hematopoietic stem cell differentiation promotes the release of prominin-1/CD133- containing membrane vesicles - a role of the endocytic-exocytic pathway. EMBO Mol Med 3:398-409
157. Ettinger AW, Wilsch-Bräuninger M, Marzesco AM, Bickle M, Lohmann A et al (2011) Proliferating versus differentiating stem and cancer cells exhibit distinct midbody-release behaviour. Nat Commun 2:503